According to the research report titled ‘Interbody Cages Market Insights, Competitive Landscape and Market Forecast-2026’, available with Market Study Report, global interbody cages market is slated to record a strong compound annual growth rate through 2026.
 

Increasing geriatric population and rising incidences of spinal & sports injuries are the major factors driving the growth of global interbody cages market. Additionally, these devices benefit physicians as they allow them to decompress nerves directly and help rebuild the spine, further augmenting the market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557571/
 

For the record, a interbody fusion cage is a surgical device which is implantable and is used to maintain the total height and decompression of the spine. When the gaps between the discs change, such interbody fusion cages are placed between the spinal cords.         
 

However, high costs related with spinal fusion procedures, lack of skilled professionals along with stringent rules & regulations associated with the use of these instruments are the factors restraining the market growth worldwide.
 

Based on product range, global interbody cages market is segmented into lumbar, thoraco-lumbar, cervical, and thoracic. Speaking of surgery type, the industry is divided into anterior, posterior, transforaminal, and lateral. Moving on to end user spectrum, the marketplace is categorized into clinic, hospital, and ambulatory surgical center including others.
 

Worldwide interbody cages industry, based on geographical analysis, is studied for nations like Spain, France, Germany, the United Kingdom, Spain, Japan, and the United States.
 

Leading players in worldwide interbody cages industry include Johnson & Johnson, NuVasive Inc., Zimmer Biomet, Medtronic plc, Orthofix Medical Inc., Prodorth Spine, Ulrich Medical USA Inc., Benvenue Medical Inc., B. Braun Melsungen AG, and Aurora Spine Inc.